US Stock MarketDetailed Quotes

REGN Regeneron Pharmaceuticals

Watchlist
  • 617.000
  • -17.230-2.72%
Close Apr 1 16:00 ET
  • 617.000
  • 0.0000.00%
Post 18:35 ET
67.45BMarket Cap16.09P/E (TTM)

Regeneron Pharmaceuticals Key Stats

Regeneron Pharmaceuticals Q4 2024 Earnings Date

Currency:USDFeb 4, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
3.75B
3.79B
+43.03M
Beat Est.
+9.08%
+10.33%
+1.15%
EPS
9.07
8.06
-1.01
Miss Est.
-10.99%
-20.90%
-11.14%
Buy

Apr 1, 2025

Regeneron Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 13 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 3.580B--
Apr 29, 20252025/Q1-- / 3.393B--
Feb 4, 20252024/Q43.789B / 3.746B--
Oct 31, 20242024/Q33.721B / 3.667B--
Aug 1, 20242024/Q23.547B / 3.387B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 3.580B--
Apr 29, 20252025/Q1-- / 3.393B--
Feb 4, 20252024/Q43.789B / 3.746B--
Oct 31, 20242024/Q33.721B / 3.667B--
Aug 1, 20242024/Q23.547B / 3.387B--

Unlock Free Earnings Estimates

Regeneron Pharmaceuticals Earnings Reports

Read more

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.